Plasma prostaglandin E2 level in Kawasaki disease

Area of Science:

• Biochemistry
• Immunology
• Pediatrics

Background:

• Kawasaki disease is an acute febrile illness associated with systemic vasculitis.
• Prostaglandins are key mediators of inflammation and immune responses.
• Understanding prostaglandin involvement in Kawasaki disease is crucial for elucidating its pathogenesis.

Purpose of the Study:

• To investigate plasma levels of prostaglandin E2 (PGE2) and prostaglandin F2 alpha (PGF2α) in patients with Kawasaki disease.
• To compare prostaglandin levels in Kawasaki disease with other inflammatory conditions like anaphylactoid purpura and infections.
• To determine the role of PGE2 and PGF2α in the inflammatory processes of Kawasaki disease.

Main Methods:

• Plasma samples were collected from patients in acute and recovery stages of Kawasaki disease.
• Plasma samples were also collected from patients with anaphylactoid purpura, bacterial/viral infections, and healthy controls.
• Plasma levels of PGE2 and PGF2α were measured using established assays.

Main Results:

• Plasma PGE2 levels were markedly increased in the acute stage of Kawasaki disease, decreasing during recovery.
• The PGF2α/PGE2 ratio was significantly decreased in the acute stage of Kawasaki disease.
• PGE2 levels remained within the normal range in patients with anaphylactoid purpura and bacterial/viral infections.

Conclusions:

• Prostaglandin E2 is selectively produced and released in Kawasaki disease, suggesting a significant role in its immunological and inflammatory reactions.
• Elevated PGE2 levels may serve as a biomarker for acute Kawasaki disease.
• The findings highlight the specific involvement of PGE2 in the pathogenesis of Kawasaki disease-associated vasculitis.